Investigating the Effect of Emetic Compounds on Chemotaxis in Dictyostelium Identifies a Non-Sentient Model for Bitter and Hot Tastant Research by Robery, Steven et al.
Investigating the Effect of Emetic Compounds on
Chemotaxis in Dictyostelium Identifies a Non-Sentient
Model for Bitter and Hot Tastant Research
Steven Robery
1, Janina Mukanowa
1, Nathalie Percie du Sert
2, Paul L. R. Andrews
2, Robin S. B. Williams
1*
1School of Biological Sciences, Centre for Biomedical Sciences, Royal Holloway University of London, Egham, United Kingdom, 2Division of Biomedical Sciences, St.
George’s University of London, London, United Kingdom
Abstract
Novel chemical entities (NCEs) may be investigated for emetic liability in a range of unpleasant experiments involving
retching, vomiting or conditioned taste aversion/food avoidance in sentient animals. We have used a range of compounds
with known emetic /aversive properties to examine the possibility of using the social amoeba, Dictyostelium discoideum, for
research into identifying and understanding emetic liability, and hence reduce adverse animal experimentation in this area.
Twenty eight emetic or taste aversive compounds were employed to investigate the acute (10 min) effect of compounds on
Dictyostelium cell behaviour (shape, speed and direction of movement) in a shallow chemotaxic gradient (Dunn chamber).
Compound concentrations were chosen based on those previously reported to be emetic or aversive in in vivo studies and
results were recorded and quantified by automated image analysis. Dictyostelium cell motility was rapidly and strongly
inhibited by four structurally distinct tastants (three bitter tasting compounds - denatonium benzoate, quinine
hydrochloride, phenylthiourea, and the pungent constituent of chilli peppers - capsaicin). In addition, stomach irritants
(copper chloride and copper sulphate), and a phosphodiesterase IV inhibitor also rapidly blocked movement. A
concentration-dependant relationship was established for five of these compounds, showing potency of inhibition as
capsaicin (IC50=11.964.0 mM) . quinine hydrochloride (IC50=44.366.8 mM) . denatonium benzoate (IC50=12964 mM) .
phenylthiourea (IC50=36665 mM) . copper sulphate (IC50=143363 mM). In contrast, 21 compounds within the cytotoxic
and receptor agonist/antagonist classes did not affect cell behaviour. Further analysis of bitter and pungent compounds
showed that the effect on cell behaviour was reversible and not cytotoxic, suggesting an uncharacterised molecular
mechanism of action for these compounds. These results therefore demonstrate that Dictyostelium has potential as a non-
sentient model in the analysis of the molecular effects of tastants, although it has limited utility in identification of emetic
agents in general.
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Introduction
Emetic research employs a range of animal models, either to
identify the emetic liability of a novel chemical entity (NCE) or to
characterise mechanisms giving rise to emesis [1]. Common
models can be divided into those that have the ability to vomit (e.g.
ferret, house musk shrew, dog and cat), and those that lack the
emetic reflex (e.g. rats and mice) [2]. In rats, pica, the ingestion of
a non-nutritive substance such as kaolin, and conditioned taste
aversion/food avoidance (CTA/CFA) are used as an emetic-like
readout [3]. Considerable variability in the sensitivity to emetic
compounds exists between animal models, due to the multiple
pathways available for induction of the reflex, and differences in
receptor pharmacology and distribution, and metabolic pathway
regulation [4,5]. This variability therefore makes it difficult to
establish a single animal model for emetic research, and encourages
a multi-model approach and increasing animal usage [5].
The very nature of emetic research has the potential to cause
considerable distress in the subjects, and some emetic compounds
(e.g. cisplatin) induce intense retching and vomiting and a
protracted emetic response that can last for several days [6]. To
reduce the number of animals needed for these adverse tests,
Holmes et al. [5] suggested a tiered approach to identify potential
emetic liability of NCEs early in compound optimisation. In this
approach, a series of individual assays would be performed in
order to reduce the final number of compounds tested on sentient
models. The first tier in this approach would involve the in silico
analysis of novel compounds under investigation, whereby
structures of known emetic efficacy are compared with novel
compounds under investigation employing previously recorded
data from in vivo studies. Secondly, a simple non-sentient model
would be used to screen for compounds showing strong effects
associated with other emetic compounds. Thirdly, tissue culture
experiments would be employed using mammalian cell lines to
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8predict emetic liability, and then finally animal models would be
incorporated. This approach could substantially reduce the number
of animal experiments by excluding many compounds with poten-
tial emetic liability at an earlier stage. This tiered approach requires
development of a simple non-sentient model system capable of
identifying emetic liability of compounds in a high-throughput type
screen.
Dictyostelium is a simple model system, widely used in the analysis
of cell signalling, development, and cell behaviour during
movement [7–10]. The genome of the model has been sequenced
[11], identifying a wide range of homologues related to human
disease proteins and associated intracellular signalling pathways.
Many of these proteins and related pathways are absent in other
simple model systems such as Saccharomyces cerevisiae and Schizo-
saccharomyces pombe [11,12], suggesting Dictyostelium may have
specific advantages over other commonly used non-sentient models.
Dictyostelium is increasingly being used in biomedical research
[12–14], in for example, the analysis of mitochondrial disease [15],
in Alzheimer’s disease signaling [16], and in understanding
pathways of microbial infection [17]. In many of these studies,
and in other more pharmacologically-oriented projects, Dictyoste-
lium has been used to analyse drug-induced changes in behaviour
during movement at a cellular level [18]. For example, in the
analysis of bipolar disorder drugs valproic acid and lithium
[19,20], for potential chemotherapy research [13,21,22], and for
the vasodilator nitric oxide [23].
In this paper, we explore the utility of using Dictyostelium as a
simple non-sentient model in the tiered approach to reducing
animals in testing for emetic liability, as proposed by Holmes et al.
[5]. This was investigated by monitoring cell behaviour (speed,
shape and direction of movement) following exposure to a range of
compounds known to induce emesis, pica or CTA/CFA. The
broad categories of compounds investigated (summarised in
Table 1) include: tastants (bitter and pungent [‘‘hot’’] compounds),
cytotoxic anti-cancer agents, selective receptor agonists and
antagonists and metal salts. Our results indicate that tastants
(both bitter and hot compounds) cause a rapid, pronounced and
concentration-dependent effect on cell behaviour, although a
range of cytotoxic and receptor agonist/antagonists compounds
giving rise to emetic or taste aversive responses had no effect.
These results suggest that Dictyostelium may provide a new model
for the analysis of bitter and hot compound perception and
signalling, although it shows little functionality as a generalised
predictor of emetic function for novel chemical entities.
Results
To investigate the utility of employing Dictyostelium as a model
for the study of tastants, cytotoxic agents, receptor agonists/
antagonists and other emetic or aversive compounds, we first
defined a standard assay. In this assay, Dictyostelium cell behaviour
was monitored by time lapse photography every 6 seconds over a
15 min period (under control conditions) (Figure 1) within a
chemotactic gradient (moving towards cAMP). Computer-gener-
ated outlines of individual cells enabled the quantification of cell
velocity, aspect and angle of movement (Figure 2 and Movie
S1). These three measurements encapsulate the complete basic
behaviour of moving cells. In addition, an X, Y coordinate plot is
provided illustrating the path length and direction of movement of
individual cells throughout the recorded period. Under these
conditions, cells exhibited stable behaviour that did not signifi-
cantly change over the 15 min period monitored (Figure 3).
This standard assay enabled the analysis of compounds with
known emetic or aversive responses in a range of species, on
Dictyostelium cell behaviour (Table 1). For each compound and
concentration, at least triplicate experiments were recorded (moni-
toring approximately 30 cells each), establishing the behaviour of
cells for five min prior to compound addition. Following drug
addition, images were then recorded for a further ten min to
monitor acute drug effects. The concentrations of compounds used
in these tests are based upon concentrations used in vivo (e.g.
copper sulphate), plasma concentrations (e.g. cisplatin) or concen-
trations shown to be active in vitro in mammalian tissues relevant to
the emetic reflex (e.g. RTX on neurones, denatonium on intestinal
epithelial cells) as shown in Table 1. A compound was determined
to have an effect on cell behaviour if the average cell velocity or
aspect changed significantly (P,0.05) between the first five min
period (prior to addition of the drug) and the final five min of the
assay. Where a substance was without apparent effect at in vitro
concentrations, experiments were then repeated at 10 – 200 fold
higher concentration (Table 1) to reduce the risk of obtaining a
false-negative result.
Of the 28 compounds screened, seven evoked a significant acute
effect on Dictyostelium cell behaviour (Tables 1 and 2, Figures 4
and 5). These were: denatonium benzoate, phenylthiourea,
quinine hydrocholoride; copper chloride and sulphate salts;
capsaicin; and rolipram. The effect of all of these compounds
was a concomitant loss of velocity, cell shape and angular
movement. Strength of effect also varied, where for example,
addition of 5 mM copper sulphate caused Dictyostelium cells to
slowly stop moving and lose shape over a ten min period (Figure 4
and Movie S2), although still generating a significant decrease in
velocity (P=0.014) and change in aspect (P=0.047). In contrast,
the addition of denatonium benzoate (5 mM) caused an
immediate loss in cell velocity and aspect (Figure 5). This
variation in time of onset for drug effects is also seen in the X,Y
coordinate plots for these compounds (Figure 3D, 4D and 5D).
Interestingly, a number of compounds that have also been shown
to have tastant activity related to those tested here did not inhibit
cell behaviour in this assay (e.g. the hot compound resiniferatoxin
and the bitter compound cycloheximide).
We then investigated the concentration-dependence of this
effect for denatonium benzoate, phenylthiourea, quinine hydro-
chloride, copper sulphate and capsaicin. A relationship between
compound concentration and change in velocity was found in all
cases, as indicated by the secondary plots (Figure 6). IC50 values
calculated from these experiments suggest the ranking of potency
to be; capsaicin (IC50=11.964.0 mM, R
2=0.78) . quinine
hydrochloride (IC50=44.366.8 mM, R
2=0.61) . denatonium
benzoate (IC50=12964 mM, R
2=0.65) . phenylthiourea
(IC50=36665 mM, R
2=0.50) . copper sulphate (IC50=14336
3 mM, R
2=0.54).
Since the block in cell behaviour during these experiments may
occur through a variety of mechanisms including cell toxicity or
death, we continued the analysis of tastants on Dictyostelium by
monitoring the reversibility of behaviour effects, a potential role of
cell death in this effect, and the results of long-term exposure
(during development). To assess the reversibility of tastant action,
we analysed the recovery of cells following compound exposure. In
these experiments, cell movement was recorded for 4.5 min in the
absence of a chemotactic (cAMP) gradient, prior to the addition of
each tastant for 4.5 min (using concentrations at eight-fold higher
that the IC50 value, representing approximate concentrations at
which the concentration-dependence curve begins to plateau
(Figure 6)). This length of exposure was chosen to show a
significant reduction in cell velocity. The buffer containing the
tastant was then replaced with fresh buffer (lacking tastant) and
cells were observed for a further 26 min (Figure 7). Under
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rise to a small non-significant drop in velocity, which then
returned towards the initial velocity by the end of the test period.
In the presence of all tastants, cells show an initial significant
reduction in velocity upon exposure compared to untreated cells,
which is consistent with earlier experiments (Figure 6). However,
following the removal of the 3 mM phenylthiourea, 1 mM
denatonium benzoate, or 350 mM quinine hydrochloride, cells
then increased in velocity, returning towards the rate of movement
of untreated cells under control conditions, and showing no
significant difference for the last time periods measured
(Figure 7). In contrast, cells exposed to 100 mM capsaicin did
Table 1. Emetic or taste aversive compounds assessed for effects on Dictyostelium behaviour during chemotaxis.
Generic Target
Target Receptor/
Mechanism of Action
Common
Name Concentration
Effect on
Dictyostelium Species Dose Range Reference
Receptor Agonist/
Tastant
T2R Receptor ligand Denatonium
Benzoate
0.05–10 mM Y R*, H* 0.01–10 mM [36,39,63,72]
Phenylthiourea 0.05–5 mM Y H* 2–5 mM [63]
Quinine HCl 0.05–1 mM Y R* 0.0082–250 mM [36,73]
TRPV1 Receptor
Agonist
Capsaicin 0.01–0.3 mM Y S 0.04–0.4 mg/kg [28,74]
Resiniferatoxin 1 mM, 10 mM N S 0.1–1000 mg/kg [27,29,75,76]
Cytotoxic Cytotoxic/DNA
Damage??
5-Fluorouracil 250 mM N F,R,S,H 35–100 mg/kg [77–79]
Actinomycin D 10 mM, 700 mM N D,R 0.13–0.25 mg/kg [79,80]
Cisplatin 50 mM, 300 mM N F,D,R,S, H 3–20 mg/kg [6,29,80–87]
Cycloheximide 5 mM N F,D 20 mg/kg [81]
Methotrexate 50 mM, 250 mM N S,H 80 mg/kg [77,78]
Streptozotocin 1 mM N H 14–27 mg/kg [88–90]
Vincristine 1 mM N R 0.1–1 mg/kg [79]
Receptor
Antagonist
Extracellular Enzyme
Inhibitor
Digoxin 1 mM N C,H 0.2–0.6 mg/kg [91,92]
PDEIV Inhibitor Rolipram 10 mM, 700 mM Y F,D,R,S 0.5–10 mg/kg [60,93–95]
SSRI/Transmitter
Uptake Inhibitor
Fluoxetine 6.5 mM N S 60 mg/kg [96]
Receptor Agonist 5-HT Receptor
Agonist
5-hydroxytryptamine 1 mM, 100 mM N S 4–10 mg/kg [96–98]
Dopamine Receptor
Agonist
Apomorphine HCl 10 mM, 1 mM N F,D,R,H 0.1–10 mg/kg [80,81,83,85,99–101]
Ligand Gated Ion
Channel Activator
Veratridine HCl 30 mM, 500 mM N D, C 0.02–0.25 mg/kg [102–104]
Neurokinin Receptor
Agonist
Substance P 1 mM N D 0.03–0.2 mg/kg [105]
Nicotinic Receptor
Agonist
Nicotine 6 mM, 100 mM N F,D,R,S,H 1.5–20 mg/kg [29,75,87,97,106–109]
Opioid Receptor Agonist Loperamide HCl 1 mM, 100 mM N F 0.5 mg/kg [85,110,111]
Other CNS depressant Lithium Chloride 10 mM N R,S,H 50–200 mg/kg [109,112,113]
Enteroendocrine
Cell Stimulant
Metformin 500 mM, 10 mM N H* 1–30 mM [114,115]
Free Radical Generator Pyrogallol 500 mM, 10 mM N S 128 mg/kg [27,116]
Gastric mucosal irritant Copper Sulphate 0.16– 5 mM Y F,D,R,S, H 5–120 mg/kg [29,85,97,109,117,118]
Copper Chloride 1.6 mM Y Based on concentratio
of copper sulphate:
[29,85,97,109,117,118]
Zinc Sulphate 1.6 mM N H 1% [119]
Prostaglandin PGF2a 1 mM, 100 mM N F,S 1–13.5 mg/kg [117,120]
A range of emetic or taste aversive compounds within the categories of tastants, cytotoxic agents, generalised receptor agonists/antagonists, and other compounds
were selected for acute exposure to chemotaxing Dictyostelium cells. These compounds have a range of target receptors and/or mechanisms of action, as indicated.
Compound concentrations employed in these Dictyostelium experiments (shown here) were derived from the experimental dose range for each compound used in
emetic-related experiments in other species: F = Ferret; D = Dog; R = Rat; S = Shrew; C = Cat; H = Human. For in vivo experiments in the rat, the table refers to the
dose at which pica was observed, for all other species it refers to the emetic dose. An effect on chemotaxis (defined as a significant change in cell velocity following
acute treatment (see Figure 3 and 4)) is represented by Y (Yes), with no effect denoted N (No). * Caused conditioned taste aversion responses in the rat or data derived
from in vitro studies.
doi:10.1371/journal.pone.0024439.t001
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However, reducing the concentration of capsaicin to 50 mM
enabled cells to recover velocity (Figure 7).
To further analyse cell viability following tastant exposure, we
then measured cell survival following 10 and 30 min treatment.
These experiments also initially employed tastant concentrations
at eight-fold IC50 values (Figure 6) and cell viability was
determined using trypan blue staining (Table 3). In the presence
of phenylthiourea, denatonium benzoate and quinine hydrochlo-
ride, the percentage of surviving cells were above 95% after
10 min of exposure and above 90% after 30 min of exposure,
indicating cell death is not the cause of the block in cell behaviour
following treatment with these compounds. However, 100 mM
capsaicin reduced cell survival to 51% and 57% after 10 and
30 min respectively. We therefore reduced capsaicin concentra-
tion to 50 mM, to show a 98% cells survived after both 10 and
Figure 1. Time-dependent image series of Dictyostelium cells during chemotaxis. A–O: Cells moving towards a gradient of cAMP (5 mM)
over a 15 min period, with images shown for each min. Two cells are indicated (arrows) over the test period. Bar =10 mm.
doi:10.1371/journal.pone.0024439.g001
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cause of capsaicin-induced block in cell movement at or below this
concentration.
Finally, we examined the chronic effect of tastants on
Dictyostelium development by exposing cells to each compound
for 24 hours during starvation on a nitrocellulose filter (Figure 8).
Under control conditions, cells were able to chemotax together to
form a mound and ultimately develop into a multicellular fruiting
body composed of a spore head held above the substratum by
dead, vacuolated stalk cells [13]. Repeating these experiments in
the presence of tastants (at eight-fold IC50 values, Figure 6) did
not inhibit fruiting body formation (Figure 8). Furthermore,
development in the presence of phenylthiourea (3 mM), quinine
hydrochloride (350 mM) and capsaicin (100 mM) did not alter the
general structure of the fruiting body (spore head and stalk),
however in the presence of denatonium benzoate (1 mM),
development was slowed, with a reduced number of immature
Figure 2. Analysis of Dictyostelium cell behaviour. Cells moving
under a chemotactic gradient were analysed using ImageProPlus
software to determine cell velocity ( mm/min); cell aspect (shape -
measured as a ratio between the diameters of cells across each axis,
where a value of 1 represents a circle); cell angle (degrees-where cell
migration was measured in comparison to the y-axis); and cell tracking
(where the co-ordinates of individual cells were illustrated following
normalisation to (0,0) at 5 min) in order to illustrate changes in
migration before and after compound addition.
doi:10.1371/journal.pone.0024439.g002
Figure 3. Analysis of Dictyostelium cell behaviour over a 15 min
period under control conditions. Mean data representing 85 cell
chemotaxis over a 15 min period for A: cell velocity; B: cell aspect; C:
cell angular movement; D: cell tracking (where the co-ordinates of
individual cells were illustrated following normalisation to (0,0) at 5 min,
represented by single lines for 0–5 min (blue) or 5–15 min (dashed red)
and cell direction has been adjusted so that cells are moving up the
page). Data from A–C is presented as mean of triplicate experiments
analysing approximately 30 cells in each.
doi:10.1371/journal.pone.0024439.g003
Table 2. Statistical significance of the concentration-
dependent acute reduction in Dictyostelium cell velocity.
Compound Concentration (mM) P-value (Velocity)
Capsaicin 0.01 NS
0.05 0.025
0.10 0.041
0.20 0.001
0.30 0.006
Copper Chloride 1.60 0.045
Copper Sulphate 0.16 NS
0.80 NS
1.20 NS
1.60 0.032
2.40 0.028
5.00 0.005
Denatonium Benzoate 0.05 NS
0.50 0.015
1.00 0.037
5.00 0.021
10.0 0.06
Phenylthiourea 0.05 NS
0.20 NS
0.50 NS
1.00 0.024
2.00 0.011
5.00 0.040
Quinine Hydrocholoride 0.05 NS
0.10 0.049
0.20 0.002
0.50 0.029
1.00 0.035
Rolipram 0.01 NS
0.70 0.007
Concentration range of compounds showing a significant acute effect on
Dictyostelium cell velocity between the first 5 and final 5 min of the assay.
T-tests performed were 2-tailed paired student t-tests, with ,30 cells measured
in each replicate. NS = not significant.
doi:10.1371/journal.pone.0024439.t002
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after prolonged incubation (48 hours; data not shown).
Discussion
Research into the mechanisms by which diverse compounds
induce emesis, and the related phenomena of pica and CTA/
CFA, traditionally employs a range of unpleasant experiments on
several animal species (primarily ferret, dog and rat), with
considerable heterogeneity in dose and response for many
compounds between different models [5]. It would thus be of
significant advantage to provide early indicators of potential
emetic liability during drug development prior to in vivo animal
studies. We therefore tested a broad spectrum of emetic and
aversive compounds from each major class of emesis-inducing
chemical group, for their acute effects on Dictyostelium behaviour
during chemotaxis. It was found that a range of structurally
discrete tastants (capsaicin – the pungent compound in chilli
peppers; and denatonium benzoate, phenylthiourea, and quinine
hydrochloride – all bitter tasting compounds), a stomach irritant
(copper containing compounds), and a phosphodiesterase IV
(PDE4) inhibitor (rolipram) (Table 1 and 2) all caused rapid
disruption of cellular behaviour, including a simultaneous decrease
in cell velocity and loss of cell shape leading to rounding.
Following a block in cell movement, the angle of movement also
approached zero degrees. Interestingly, no treatments were found
to cause changes in cell direction independent of speed or cell
shape. It is worth noting that a range of emetic/aversive
compounds that have been previously shown to cause chronic
effects on Dictyostelium development, including lithium and
cytotoxic compounds such as cisplatin [20,22,24,25], did not
acutely affect cell velocity, shape or angular direction in this study.
The differences in compound effects may be due to the short
exposure time (ten min) used here, in comparison to previous
reports that employ treatment times of 1–24 hours.
Capsaicin, a vanilloid, is the active compound found in chillies
responsible for causing a burning taste sensation and it has been
demonstrated to be an agonist for the transient receptor potential
vanilloid-1 (TRPV1) receptor [26]. The TRPV1 receptor has been
implicated in the induction of emesis via the acute release of
endogenous substance P [27,28]. Identification of the mechanism
of action of Capsaicin in Dictyostelium may provide a novel model
for molecular research in this area, and provide further insight into
a mechanism of action (through either receptor activation or
inhibition, or via intracellular cell signalling pathway regulation).
Initial examination of the Dictyostelium proteome failed to find any
proteins with significant homology to known human, mouse or
worm (C. elegans) TRPV1 proteins (based upon BLAST analysis
with TRPV receptors - Table S1), and this therefore raises the
possibility of an alternative mechanism of action of pungent tasting
compounds in regulating Dictyostelium cell behaviour. Surprisingly,
the ultra potent analogue of capsaicin, resiniferatoxin, did not
significantly affect Dictyostelium cell behaviour at the concentrations
used here, although it is capable of inducing emesis in animal
models [28,29]. It is unclear if structural or physicochemical
differences between the two compounds give rise to altered efficacy
in regulating the Dictyostelium target.
Bitter taste has been thought to be perceived in humans since a
pre-Neanderthal age, providing a mechanism for identifying
potentially toxic substances [30]. It has been shown that bitter
taste can initiate the sensation of nausea [31]. Response to bitter
tasting compounds has also been shown across a wide spectrum of
model systems from mammals to frogs, fish, Drosophila, and C.
elegans [32–38]. Denatonium benzoate, phenylthiourea and
Figure 4. Analysis of Dictyostelium cell behaviour with addition
of 5 mM copper sulphate after 5 Min. Mean data representing 124
cell chemotaxis over a 15 min period following addition of copper
sulphate (5 mM) at 5 min (arrow) for A: cell velocity; B: cell aspect; C:
cell angular movement; D: cell tracking (where the co-ordinates of
individual cells were illustrated following normalisation to (0,0) at 5 min,
represented by single lines for 0–5 min (blue) or 5–15 min (dashed red)
and cell direction has been adjusted so that cells are moving up the
page). Data from A–C is presented as a mean of triplicate experiments
analysing approximately 40 cells in each.
doi:10.1371/journal.pone.0024439.g004
Figure 5. Analysis of Dictyostelium cell behaviour with addition
of 5 mM denatonium benzoate after 5 Min. Mean data repre-
senting 89 cells chemotaxis over a 15 min period following addition of
denatonium benzoate (5 mM) at 5 min (arrow) for A: cell velocity; B:
cell aspect; C: cell angular movement; D: cell tracking (where the co-
ordinates of individual cells were illustrated following normalisation to
(0,0) at 5 min, represented by single lines for 0–5 min (blue) or 5–
15 min (dashed red) and cell direction has been adjusted so that cells
are moving up the page). Data from A–C is presented as a mean of
triplicate experiments analysing approximately 30 cells in each.
doi:10.1371/journal.pone.0024439.g005
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significant and dramatic changes in cell velocity and aspect. All
three compounds are proposed T2R receptor ligands involved in
this bitter taste detection, and this mechanism functions in emesis
in humans at high concentrations [39–42]. The common effect
observed here for three structurally-independent bitter compounds,
at concentrations used in emetic based research (Table 1), suggests
a T2R receptor-like mechanism of action in Dictyostelium. However,
BLAST analysis of the Dictyostelium proteome using 25 different
human T2R receptors (with these proteins sharing a 30–70%
homology [[43–45]); 24 mouse [43], six insect (Drosophila;N C B I
36094, 117484, 38935, 117498, 117349, 117492) [34], three worm
(C. elegans; NCBI 178326, 177117, 188314) [32,37] and three
candidate fish (zebrafish; NCBI 664690, 553134, 798975) [35,46]
bitter receptors, again did not identify any Dictyostelium proteins
showing significant homology within its genome (See Table S2).
Furthermore, other related receptors such as the mammalian
TRPM5 receptor (NCBI 29850), also associated with bitter taste
detection [47,48], did not have recognisable Dictyostelium homo-
logues (based on BLAST analysis – see Table S3). Although the
lack of recognised bitter receptors in Dictyostelium (as defined by
protein sequence homology to other species) suggests a potential
novel mechanism for the detection of bitter compounds, it must be
noted that receptors for other taste-related compounds have been
found in other models that lack homology to established tastant
receptors (e.g. sweet receptors in Drosophila [49]). Identifying the
mechanism (or molecular target) of bitter taste perception in
Dictyostelium may thus provide a novel mechanism of action for bitter
tasting compounds, leading to the subsequent analysis of this
mechanism in humans.
Copper compounds are essential in the diet but at higher
concentrations can causes gastrointestinal upsets, which include
nausea, vomiting, cramps and diarrhoea [50,51]. This has lead to
the formation of regulatory guidelines for copper levels in drinking
Figure 6. Concentration-dependent reduction of cell velocity for emetic and taste aversive compounds. Reduction in cell velocity
compared to untreated cells was plotted against log10 concentrations, where compound concentration was chosen from those showing a non-
significant effect on cell behaviour; up to a maximum of a 200-fold increase from this value. All data is presented as a mean 6 S.E.M of triplicate
experiments, comparing mean cell velocity during the first 5 min and final 5 min with increasing concentration.
doi:10.1371/journal.pone.0024439.g006
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in mammalian systems suggests the gastro-duodenal luminal
concentration of copper sulphate is the key to emesis induction,
thus implicating a gut mucosal-triggered reaction, and this is
supported by neurophysiological studies [52–56]. However, the
molecular emetic mechanism of copper in the gut remains unclear.
Several studies have analysed a role for copper in Dictyostelium [57],
and these have suggested that cells are highly resistant to copper
through high cellular export [57]. The molecular mechanism of
copper may be due to an inhibition of ATP-dependent ion
currents, controlled by P2X receptors [58,59].
Phosphodiesterase IV (PDE4) inhibitors are proposed for use as
anti-inflammatory agents (e.g. in asthma) but may cause nausea
and vomiting as side-effects [60]. Phosphodiesterases are respon-
sible for degrading cAMP and cGMP in Dictyostelium [61], and
there is one potential PDE4 homologue in Dictyostelium that shares
a 33–35% identity with the 4 human isoforms A–D. Inhibition of
phosphodiesterases would be expected to elevate extracellular
cAMP levels, leading to saturation of cAMP receptors in
chemotaxis, and thus the observed inhibition of cell behaviour
shown in our assay. Rolipram did not exert an effect on
Dictyostelium cell behaviour at low concentrations (10 mM), but
blocked cell movement at higher concentrations (700 mM). The
high concentration required for this effect may thus reflect a non-
specific action of Rolipram on Dictyostelium phosphodiesterases
[62].
The acute block in Dictyostelium cell behaviour caused by tastants
may occur through a range of mechanisms including interaction
with unknown receptor(s) or other molecular target(s), or through
basic cytotoxicological mechanisms. To investigate these potential
toxicological mechanisms, we carried out a range of short- and
long-term exposure experiments on Dictyostelium. Using a concen-
tration derived from the IC50 value for each compound (eight fold
higher), we initially showed that all cells treated with bitter
compounds recovered from acute (4.5 min) exposure (Figure 7).
This suggests that inhibition of cell behaviour by these tastants is
not through a cytotoxicological mechanism. This was then
confirmed by measuring cell death following 10 and 30 min
Figure 7. Analysis of Dictyostelium cell behaviour recovery post-tastant exposure. Mean data representing cell velocity during random cell
movement over a 35 min period, with average cell velocity measured for 4.5 min under control conditions (at 24.5–0 min), prior to the addition of
tastants at 0 min (D), followed by removal of tastants at 4.5 min (W), and the recording of recovery up to 31 min. Tastant concentrations used are:
1 mM denatonium benzoate, 3 mM phenylthiourea, 350 mM quinine hydrocholide, and 50 mM capsaicin. Data is presented as a mean 6 S.E.M for
each 4.5 min period, with triplicate experiments analysing approximately 30 cells in each. Grey bars indicate the equivalent time periods used in the
analysis of cell velocity comparing control and each condition. N/S = non significant, * = P,0.05.
doi:10.1371/journal.pone.0024439.g007
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viability (Table 3). In contrast 100 mM capsaicin treatment did
not enable cell recovery over 26 min, and caused a large reduction
in cell viability following 10 min exposure. This effect however is
likely to be maximal, since increased exposure (30 min) to
capsaicin did not further reduce cell viability. However, reduction
of capsaicin concentration to 4-fold over IC50 values enabled cells
to recover velocity and did not reduce cell viability. These
combined experiments suggest that tastants examined here do not
function through an acute toxicological mechanism to block
Dictyostelium cell behaviour.
To extend these toxicological assays for the analysis of longer
exposure periods, we also examined the role of tastants on
Dictyostelium development (Figure 8). In these experiments, cells
were exposed to tastants (again at eight-fold IC50 values) for
24 hours, and the ability to develop into mature fruiting bodies
was monitored as previously described [10–12]. Long term
exposure to all compounds did not block fruiting body forma-
tion, clearly indicating that these compounds are not lethal to
Dictyostelium at high concentrations for extended exposure.
Phenylthiourea, quinine and capsaicin exposure also did not alter
fruiting body morphology, whereas denatonium benzoate slowed
development, with immature fruiting bodies present after 24
hours, that later developed into mature structures. These
combined cytotoxicological and developmental experiments sug-
gest that bitter and hot compounds do not block Dictyostelium
behaviour through toxic or irreversible mechanisms.
All pharmacological studies must consider drug concentrations,
to differentiate between potential target-specific and non-specific
effects. In mammalian experimental systems, bitter tasting
compounds have been shown to cause effects on mouse intestinal
STC-1 [63,64] as well transfected HEK-293 cells [65] at similar
concentrations to those used in our experiments (up to 10 mM and
1 mM respectively), suggesting that Dictyostelium is as sensitive as
other models for detecting bitter taste. Similarly, capsaicin has also
been used in human-based taste experiments at concentrations
shown here to affect Dictyostelium behaviour [66,67] (100 mM).
Since the molecular mechanisms of these compounds in
chemotactic cell behaviour remains unknown, it is not possible
to infer a commonly targeted signalling pathway. However, in
mammalian systems, T2R receptor signalling is regulated by a
TRPV1-like receptor, TRPM5, thus both ‘bitter’ and ‘hot’
compounds share a common signalling pathway [68]. Although
Dictyostelium does not contain proteins with high amino acid
sequence similarity to either of these receptors, further investiga-
tion will be necessary to determine if Dictyostelium’s ability to detect
these compounds involves a common signalling pathway.
An important limitation of this work is that primary assay used
in this investigation only monitors the acute effects of test
substances (within 10 min of exposure), thus any delayed effect
would not be observed. For example, cytotoxic agents (e.g.
cisplatin) used in anti-cancer treatments cause DNA damage, and
this effect may not lead to significant changes in cell behaviour
within the ten min response time recorded. These compounds do,
however, give rise to a chronic block in development following
longer exposure [22].
Conclusions
A broad range of emetic and aversive compounds within the
categories of tastants (e.g. bitter and hot compounds), cytotoxic
agents, or generalised receptor agonists/antagonists were tested to
determine if Dictyostelium cell behaviour could be used to
Table 3. Analysis of tastants on Dictyostelium cell viability.
Compound/
Exposure
Mean Cell
Count (alive) S.E.M
Mean Cell
Count (dead) S.E.M
Cell
Total
Cell Viability (%
cells Surviving) P-value
Time (Min)
Control
10 135 2.2 1 0.6 136 99 N/A
30 135 4.3 0 0 135 100 N/A
1m MD B
10 181 16.5 7 0 188 96 0.006
30 183 5.9 16 3.2 199 92 0.021
350 mM QHCl
10 139 12.1 1 1 140 99 NS
30 146 2.59 3 1.2 150 97 NS
3 mM PTU
10 128 8.7 0 0 128 100 NS
30 119 7.1 4 0.9 123 97 0.021
100 mM Capsaicin
10 87 1.5 83 7.7 170 51 0.002
30 74 4.1 57 1.8 131 57 0.0004
50 mM Capsaicin
10 174 1.3 3 1.5 177 98 NS
30 150 8.9 3 0.8 153 98 0.021
Chemotactically competent Dictyostelium cells were exposed to compounds at indicated concentrations and cell viability assessed after 10 and 30 min using trypan
blue. All experiments were performed in triplicate. N/A = Not applicable NS = Not significant.
doi:10.1371/journal.pone.0024439.t003
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show that Dictyostelium provides a limited model for emetic or
aversive compound identification. However, Dictyostelium may
enable an exciting new avenue for research into the molecular
mechanisms of bitter and hot compounds, since these compounds
have a rapid and strong effect on behaviour, the compounds have
an uncharacterised molecular mechanism of action, and we have
demonstrated the compounds are unlikely to affect cell behaviour
via toxicological means. Further investigation into the molecular
mechanism of tastants on Dictyostelium may thus provide novel
mechanism(s) of bitter and hot compound action.
Materials and Methods
Chemicals
The following chemicals were obtained from Sigma Aldrich Co.
Ltd (Dorset, UK), and are provided with catalogue numbers: 5-
fluorouracil (2,4-Dihydroxy-5-fluoropyrimidine; F6627), actinomy-
cin D (2-Amino-(N,N)-1-bis(hexadecahydro-6,13-diisopropyl-2,
5, 9-trimethyl-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1]-[1,4,7,10,13]
oxatetraazacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenox-
azine-1,9-dicarboxamide; A1410), capsaicin (8-Methyl-N-vanillyl-
trans-6-nonenamide; M2028), cisplatin (cis-Dichlorodiammine pla-
tinum(II); 479306), copper chloride (203149), copper sulphate
(cupric sulphate pentahydrate; C8027), cycloheximide (3-[2-(3,5-
Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl] glutarimide; C7698),
denatonium benzoate (N,N-Diethyl-N-[(2,6-dimethylphenyl carbam-
oyl) methyl] benzyl ammonium benzoate; D5765), digoxin (12b-
Hydroxydigitoxin; D6003), fluoxetine ((6)-N-Methyl-c-[4-(trifluor-
omethyl)phenoxy]benzenepropanamine hydrochloride; F132), lith-
ium chloride (L9650), loperamide hydrochloride (4-(p-Chlorophe-
nyl)-4-hydroxy-N,N-dimethyl-a,a-diphenyl-1-piperidinebutyramide
hydrochloride; L4762), metformin (1,1-Dimethylbiguanide hydro-
chloride; 04635), methotrexate (4-Amino-10-methylfolic acid hy-
drate), nicotine (3-(1-methylpyrrolidin-2-yl)pyridine; M4010),
PGF2a ((5Z,9a,11a,13E,15S)-9,11,15-Trihydroxyprosta-5,13-die-
noic acid tris salt; P0424), phenylthiourea (1-Phenyl-2-thiourea;
P7629), pyrogallol (1,2,3-Trihydroxybenzene; P0381), quinine
hydrochloride ((R)-[(2S,4R,5R)-5- ethenyl-1 -azabicyclo [2.2.2]
octan-2-yl]- (6-methoxyquinolin-4-yl) methanol dihydrate hydro-
chloride; Q1125), resiniferatoxin (4-Hydroxy-3-methoxy- [(2S,3aR,
3bS,6aR,9aR,9bR,10R,11aR)- 3a,3b,6,6a,9a, 10,11,11a-octahydro-
6a-hydroxy-8, 10-dimethyl-11a-(1-methylethenyl)-7-oxo-2-(phenyl-
methyl)-7H-2,9b -epoxyazuleno[5,4-e]-1,3-benzodioxol-5-yl] benze-
neacetate; R8756), rolipram (4-[3-(Cyclopentyloxy)-4-methoxyphe-
nyl]-2-pyrrolidinone; R6520), streptozocin (N-(Methylnitro-
socarbamoyl)-a-D-glucosamine;S0130),veratridine(3-Veratroylver-
acevine; V5754), vincristine (22-Oxovincaleukoblastine sulfate salt;
V8388) and zinc sulphate monohydrate (96495). The following
compound (with catalogue number) were obtained from Tocris
Bioscience Ltd: (Bristol, UK) 5-hydroxytryptamine (3-(2-Ami-
noethyl)-1H-indol-5-ol hydrochloride; 3547), apomorphine hydro-
chloride (R(–)-10,11-Dihydroxyaporphine; 2073) and substance
P ((2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-5-(diami-
nomethylideneamino) pentanoyl]pyrrolidine-2-carbonyl]amino]-
hexanoyl]pyrrolidine-2-carbonyl]amino]-N-[(2S)-5-amino-1-[[(2S)-
1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-
2-yl] amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-
1-oxo-3-phenylpropan-2-yl] amino]-1-oxo-3sphenylpropan-2-yl]a-
mino]-1,5-dioxopentan-2-yl]pentanediamide; 1156). All compounds
were dissolved in dimethylsulfoxide (DMSO) (5-fluorouracil, actino-
mycin D, cycloheximide, digoxin, fluoxetine, rolipram, quinine
hydrochloride, capsaicin and resiniferatoxin) or phosphate buffer
(16.5 mM KH2PO4,3 . 8m MK 2HPO4, pH 6.2) (lithium chloride,
cisplatin, streptozotocin, vincristine, metformin, pyrogallol, copper
sulphate, copper chloride, zinc sulphate, substance P, nicotine,
loperamide hydrochloride, PGF2a, denatonium benzoate, phenylthio-
urea), apart from 5-hydroxytryptamine, apomorphine hydrochloride
(dissolved in 0.9% ascorbic acid); methotrexate and veratridine
(dissolved in 0.1% sodium hydroxide).
Cell Behaviour Assay
To prepare Dictyostelium cells (Ax2) for behaviour analysis
experiments, cells were grown in shaking suspension in Axenic
medium (Formedium Co. Ltd, Norfolk, UK), washed and
resuspended in phosphate buffer at 1.7610
6 cells/ml. Cells were
then pulsed for 5 hours with 30 nM cyclic adenosine monophos-
phate (cAMP) (Sigma Co. Ltd, Dorset, UK) at 6 min intervals
whilst shaking at 120 rpm. Cells were then washed in phosphate
buffer, resuspended at 1610
7 cells/ml, and used in a Dunn
chamber (Hawksley, Sussex, UK) assay [69], migrating toward
5 mM cAMP. A stable chemotactic gradient was allowed to form
over a 30 min period, prior to recording cell shape and position
using an Olympus IX71 microscope at 40x magnification with a
QImaging RetigaExi Fast1394 digital camera. Cell images were
recorded every 6 seconds over a 15 min period, with the initial
5 min period recorded prior to addition of test compounds (within
a1 0mL aliquot diluted in 5 mM cAMP) to the outer well of the
Dunn chamber. Subsequent images were recorded over the
following ten min period for each compound, and at each
Figure 8. Analysis of tastants on Dictyostelium development.
Cells were allowed to develop over 24 hours in the presence of control
conditions, 3 mM phenylthiourea, 1 mM denatonium benzoate, 350 mM
quinine hydrochloride and 100 mM capsaicin. All images are represen-
tative of triplicate experiments indicating cell survival after 24-hours
exposure to each compound. Scale bar represents 1 mm.
doi:10.1371/journal.pone.0024439.g008
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for each drug/concentration and an average cell number of ,30
cells quantified per experiment. Cell recordings were prepared in
the second quadrant of the Dunn chamber, enabling cell angular
movement to be recorder at around 250 degrees. Solvent only
controls were carried out for all experiments to ensure readouts
were based upon compounds listed, with for example, no effect of
DMSO shown at 0.6%– the highest concentration used in the
experiments described here.
Dictyostelium Recovery Following Tastant Exposure
Dictyostelium cells (Ax2) were pulsed as described above, re-
suspended at 1.7610
5 cells/mL, and 250 mL aliquots of cells
were added to Lab-Tek 8-well chambered coverglass wells
(Thermo Fisher, Leicestershire, UK) and allowed to adhere for
45 min. Cell movement was recorded as above at intervals of 18
seconds for a total of 35 min (in the absence of a chemotactic
gradient). Cells were allowed to establish a base-line velocity for
4.5 min, prior to the addition of 10 mL of tastant to give indicated
final concentrations. Following 4.5 min tastant exposure, cell
buffer containing tastants was aspirated from the chamber and
replaced with 250 mL phosphate buffer (over a 30 second period),
and cells were monitored for a further 25.5 min. All experiments
were performed in a minimum of triplicate individual assays, at
each compound concentration.
Cell Viability Assay
Dictyostelium cells (Ax2) were pulsed as described, re-suspended at
2.5610
5 cells/mL, exposed to tastants (at indicated concentra-
tions) for 7 or 27 min and then stained with 0.4% trypan blue
solution (final concentration 0.067%) for 3 min prior to live
counting. Dead cells were identified as a distinctive blue colour
since live cells did not change colour. Experiments were performed
in triplicate.
Development Assay
Dictyostelium development assays were performed in triplicate
experiments as previously described [13,70,71].
Data Analysis and Statistics
Changes in cell velocity, aspect (the ratio between the major
and minor axes of an elliptical shape such as a cell) and angular
movement (Figure 2) were monitored for every cell within each
of the 600 frames recorded over the 15 min period and analysed
by ImagePro software (Media Cybernetics, Buckinghamshire,
UK). Compound effects were compared using the mean velocity
and aspect of cells between the first 5 min and the final 5 min
and significance was determined using a two-tailed paired
student t-test (P#0.05). Angle was also measured throughout in
order to observe any changes in the direction of cell movement.
The relative co-ordinates of cells (X,Y) were also mapped and
represented in a line-tracking plot whereby the co-ordinates of
cells at 5 min (when the compound was added) were normalised
to (0,0).
In quantifying velocity, concentration-related drug response was
calculated by subtracting the mean velocity of cell movement in
the final five min from the mean velocity in the first 5 min for each
compound at each concentration. These were plotted against drug
concentration (log10) to quantify the change in velocity with drug
concentration. A non-linear three parameter log 10 concentration
response curve was fitted by GraphPad Prism (GraphPad Software
Inc v5.02, San Diego, USA) using a least squares fit. Using
GraphPad, the subsequent concentration at half maximal compound
inhibition (IC50) was calculated well as the R
2 value in order to
display the accuracy of the curve fit.
Cell velocity was quantified in the Dictyostelium recovery
experiments as described above. Significance was determined
using unpaired one-tailed student t-tests (based on a unidirectional
drop in velocity as observed in Dictyostelium cell behaviour assay) by
comparing mean velocity of control cells and equivalent mean
velocities at each compound concentration. Tastant dependent
effects were determined by comparing 0–4.5 min and 27-31 min
periods (grey bar) between control and tastant treated cells to
assess initial decrease in cell velocity and recovery of velocity
(Figure 7).
Significance was determined in cell viability assays by com-
paring the percentage cell viability between control conditions and
each compound concentration using paired 2-tailed student t-tests.
Supporting Information
Movie S1 Dictyostelium chemotaxis was monitored by
time-lapse photography to record cells moving within a
Dunn Chamber towards the chemo-attractant, cAMP,
across the screen from left to right. Images were taken every
6 seconds over a 15 minute period. Computer generated cell
outlines enables average cell velocity, shape and direction of
movement to be quantified.
(AVI)
Movie S2 Dictyostelium chemotaxis was monitored by
time-lapse photography to record cells moving within a
Dunn Chamber towards the chemo-attractant, cAMP,
across the screen from bottom right to top left. Images
were taken every 6 seconds over a 15 minute period. Computer
generated cell outlines enables average cell velocity, shape and
direction of movement to be quantified. Cell movement was
recorded over a 5 minute period, prior to the addition a range of
emetic or aversive compounds (indicated by a black screen flash),
and cell behaviour was recorded for a further 10 minutes. In the
movie shown here, the stomach irritant copper sulphate (5 mM )
was added, causing Dictyostelium cells to slowly stop moving and
lose shape over the ten min period tested.
(AVI)
Table S1 Homology search results (BLAST analysis) of
the Dictyostelium genome for proteins showing amino
acid similarity to TRPV receptors from multiple spe-
cies. Potential homologues are defined by an E-value of less than
1.00E-40 [11], thus Dictyostelium does not contain proteins showing
significant sequence similarity to be considered as homologues.
(DOCX)
Table S2 Homology search results (BLAST analysis) of
the Dictyostelium genome for proteins showing amino
acid similarity to known bitter receptors from multiple
species. Potential homologues are defined by an E-value of less
than 1.00E-40 [11], thus Dictyostelium does not contain proteins
showing significant sequence similarity to be considered as
homologues. N/A = Not applicable.
(DOCX)
Table S3 Homology search results (BLAST analysis) of
the Dictyostelium genome for proteins showing amino
acid similarity to TRPM5 receptors from human and
mouse. Potential homologues are defined by an E-value of less
than 1.00E-40 [11], thus Dictyostelium does not contain proteins
showing significant sequence similarity to be considered as
homologues. N/A = Not applicable.
(DOCX)
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